Analgesia for patients undergoing minimally invasive major abdominal surgery using Intrathecal Morphine with local anaesthetic. The AIM Study.

Phase 4

• Conditions: Anaesthesiology; Quality of recovery; Postoperative recovery; Anaesthesiology - Pain management; Anaesthesiology - Anaesthetics

• Registration Number: ACTRN12623001347651
• Lead Sponsor: Alfred Health

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2023-12-20
• Last Update Posted: 8 January 2024

Recruitment & Eligibility

• Status: ot yet recruiting
• Sex: All
• Target Recruitment: 280

Inclusion Criteria

•Greater than or equal to 18 years old
•Patients scheduled for elective major laparoscopic, lap-assisted or robotic abdominal surgery, and
•Major surgery is that with a planned operative time of over 2 hours

Exclusion Criteria

•< 18 years old
•Patient declines enrolment or inability to consent
•Contraindication to intrathecal morphine
•Contraindication to a neuraxial injection, including; injection site concerns, coagulopathy (including administration of anticoagulant), or untreated sepsis
•Cognitive impairment or language proficiency leading to inability to complete QoR-15 questionnaire or understand the pain scores
•Chronic pain, including baseline opioid use prior to hospital admission

Study & Design

• Study Type: Interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Quality of recovery[Quality of recovery 15 score (QoR-15) where a clinically important difference is regarded to be 6 points or more Post operative day 1]